MNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients
| dc.contributor.author | Mosab Nouraldein Mohammed Hamad | |
| dc.date.accessioned | 2026-09-12T22:02:52Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | COVID.19 Pandemic is a real disaster facing the globe, and up to date its uncontrollable , due to absence of data about the real mechanism upon which this virus overcome immune system and induce lethal symptoms certainly among aged and those with low-level of immunity. MNAD hypothesis based protocol aimed to measure validity of combination Minocycline as antibiotic, N. acetyl cysteine as antioxidant, aspirin as anticoagulant and vitamin D as immune regulator to treat COVID.19 infection. This protocol opened and implemented by any institutions or health authority after permission of the corresponding author of it. | |
| dc.identifier.issn | 2518-3222 | |
| dc.identifier.uri | https://dspace.eaeu.edu.sd/handle/123456789/1012 | |
| dc.language.iso | other | |
| dc.publisher | جامعة الشيخ عبدالله البدري | |
| dc.title | MNAD Hypothesis Based Protocol Proposed for Treatment of COVID.19: Assessment of Minocycline, N. acetylcysteine, Aspirin & vitamin D (MNad) Theory for treatment of COVID.19 Adults Patients |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- SJBR511325-330FTRevised3.pdf
- Size:
- 538.04 KB
- Format:
- Adobe Portable Document Format